Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study
Authors:
Open Access
- 19 September 2024
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 33 (9) , e70012
Abstract
Purpose: The magnitude of repeat exposures to culprit medications after hospital discharge is not well studied. We combined prospective cohort data with administrative health data to understand the frequency of repeat exposures to culprit medications after discharge and the risk factors for their occurrence.Methods: This was a retrospective analysis of three prospective cohorts of patients who presented to the hospital with an adverse drug event in British Columbia, from 2008 to 2015 (n = 849). We linked prospectively identified adverse drug events to administrative data to examine patterns of redispensing of culprit medications. We used Cox regression to assess risk factors for re‐exposure, and conducted subgroup analyses for essential vs. nonessential medications.Results: Among 849 diagnosed adverse drug events, 45.2% had subsequent culprit medication redispensing within a year of hospital discharge. The factors associated with re‐exposures included atrial fibrillation, adverse drug event type (e.g. adverse reaction), culprit medication type, and longer historical duration of medication use.Conclusions: Re‐exposures to culprit medications occurred in almost half of the adverse drug events diagnosed in emergency departments. Many of these were appropriate re‐exposures to essential medications for indications in which the risk of uncontrolled disease likely outweighed the risk of a repeat adverse event. More research is needed to understand re‐exposures to nonessential medications or medications with safer alternatives.Keywords
Funding Information
- Canadian Institutes of Health Research
This publication has 20 references indexed in Scilit:
- Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug eventsBritish Journal of Clinical Pharmacology, 2024
- Validating methods used to identify non‐adherence adverse drug events in Canadian administrative health dataBritish Journal of Clinical Pharmacology, 2024
- STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progressExpert Review of Clinical Pharmacology, 2019
- Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug EventsAcademic Emergency Medicine, 2018
- Clinical Decision Rules to Improve the Detection of Adverse Drug Events in Emergency Department PatientsAcademic Emergency Medicine, 2012
- A merican G eriatrics S ociety Updated B eers C riteria for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2012
- Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort studyBMJ, 2009
- Repeat adverse drug reactions causing hospitalization in older Australians: a population‐based longitudinal study 1980–2003British Journal of Clinical Pharmacology, 2006
- Represcription After Adverse Drug Reaction in the Elderly: A Descriptive StudyArchives of internal medicine (1960), 2006
- Applied Logistic Regression2000